XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>Brookfield reaffirms its interest in Grifols, ask more time for analysis, sources say</title></head><body>

By Andres Gonzalez

LONDON, Sept 30 (Reuters) -Canadian fund Brookfield BN.TO reaffirmed its interest in a potential takeover of Spanish drugmaker Grifols GRLS.MC and requested more time to complete due diligence for its possible bid, two sources with knowledge of the matter said on Monday.

Brookfield sent a letter on Monday to the board asking for a few more weeks to complete the process that began this summer, according to the people, who spoke on condition of anonymity because they were not authorized to speak publicly.

The Canadian private equity firm said in July it was interested in launching a takeover bid jointly with the Grifols family, pending successful completion of due diligence.

Brookfield is expected to execute the deal in collaboration with other investors in its funds, a different source with knowledge of the talks said earlier this year. It has also begun discussions with banks to secure funding for the potential takeover.

Since early January, Gotham City Research, a short-seller fund, has released multiple reports accusing Grifols of overstating earnings and understating debt, which Grifols denies.

These accusations have wiped out around 35% of the Barcelona-based company's market value.

Spain's stock market regulator CNMV said last week it was sanctioning short-seller fund Gotham City Research for allegedly manipulating the market for Grifols shares, and the pharma group for defective financial reporting.



Reporting by Andres Gonzalez, editing by Susan Fenton

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.